Fresenius poised to issue more debt for NxStage buy
German dialysis services provider Fresenius will issue debt backing its $2bn acquisition of US peer NxStage “in due course”, a source close to the situation told GlobalCapital on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: